These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 20146979

  • 1. [Peritonitis due to glycopeptides-resistant Staphylococcus epidermidis].
    Watine J, Ciobotaru M, Lombart D, Thomas K, Amirou M.
    Ann Biol Clin (Paris); 2010; 68(1):99-103. PubMed ID: 20146979
    [Abstract] [Full Text] [Related]

  • 2. Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia.
    Rodriguez CA, Agudelo M, Cataño JC, Zuluaga AF, Vesga O.
    J Infect; 2009 Oct; 59(4):277-80. PubMed ID: 19698745
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy.
    Sieradzki K, Roberts RB, Serur D, Hargrave J, Tomasz A.
    J Clin Microbiol; 1999 Jan; 37(1):39-44. PubMed ID: 9854061
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Should cefazolin or vancomycin be used for initial empiric coverage for Staphylococcus aureus in peritoneal dialysis associated peritonitis?
    Hansson JH.
    Semin Dial; 2011 Jan; 24(4):449-50. PubMed ID: 21851410
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double-blind clinical trial.
    Innes A, Burden RP, Finch RG, Morgan AG.
    Nephrol Dial Transplant; 1994 Jan; 9(7):797-9. PubMed ID: 7970121
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of a synthetic antimicrobial peptidomimetic versus vancomycin in a Staphylococcus epidermidis device-related murine peritonitis model.
    Cavanagh JP, Granslo HN, Fredheim EA, Christophersen L, Jensen PØ, Thomsen K, Van Gennip M, Klingenberg C, Flaegstad T, Moser C.
    J Antimicrob Chemother; 2013 Sep; 68(9):2106-10. PubMed ID: 23645587
    [Abstract] [Full Text] [Related]

  • 12. Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.
    Giacometti A, Ghiselli R, Cirioni O, Mocchegiani F, Orlando F, Del Prete MS, D'Amato G, Silvestri C, Saba V, Scalise G.
    J Antimicrob Chemother; 2003 Oct; 52(4):724-6. PubMed ID: 12951347
    [Abstract] [Full Text] [Related]

  • 13. Detection of vancomycin heteroresistant Staphylococcus haemolyticus and vancomycin intermediate resistant Staphylococcus epidermidis by means of vancomycin screening agar.
    Chiew YF, Charles M, Johnstone MC, Thompson KM, Parnell KD, Penno EC.
    Pathology; 2007 Jun; 39(3):375-7. PubMed ID: 17558874
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD.
    Vargemezis V, Thodis E, Pasadakis P, Martinis G, Kousta E.
    Adv Perit Dial; 1990 Jun; 6():123-5. PubMed ID: 1982788
    [Abstract] [Full Text] [Related]

  • 15. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
    Streuli JC, Exner GU, Reize CL, Merkofer C, Scott CP, Zbinden R.
    Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
    [Abstract] [Full Text] [Related]

  • 16. Treatment with intravenous daptomycin for a peritonitis relapse caused by Staphylococcus epidermidis.
    Levy F, Camarero Temiño V, Blasco Mollá A, Ortega Lafont MP, Abaigar Luquin P, Izquierdo Ortiz MJ, Torres Torres G.
    Nefrologia; 2011 Apr; 31(3):374-5. PubMed ID: 21629350
    [No Abstract] [Full Text] [Related]

  • 17. Spontaneous bacterial peritonitis in terminal renal failure.
    Cengiz CK.
    Clin Nephrol; 2007 Oct; 68(4):258-61. PubMed ID: 17969496
    [Abstract] [Full Text] [Related]

  • 18. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
    Cartolano GL, Cheron M, Benabid D, Leneveu M, Boisivon A, Association of Hospital Bacteriologists, Virologists and Hygiene Professionals.
    Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
    [Abstract] [Full Text] [Related]

  • 19. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
    Bourgeois F, Bingen E, Lambert-Zechovsky N.
    Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
    Kratzer C, Rabitsch W, Hirschl AM, Graninger W, Presterl E.
    Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.